Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

L-Phenylalanine and UVA Therapy for Vitiligo Repigmentation

This session explores the evidence for using L-phenylalanine as an adjunct to UVA phototherapy for repigmentation in vitiligo. It explains the amino acid's role as a melanin precursor, cites a systematic review showing a small but statistically significant benefit, and covers typical protocols, risks, and precautions like medical supervision and PKU avoidance.

  • Does L-phenylalanine help with repigmentation, especially when combined with UVA light therapy?

  • Yes, there is evidence suggesting that L-phenylalanine may help with repigmentation, particularly when used alongside UVA light therapy, most commonly in the context of vitiligo treatment.

    Here's what the research indicates:

    How It Works

    L-phenylalanine is an essential amino acid that serves as a precursor to tyrosine, which is a building block for melanin — the pigment responsible for skin color. The idea is that by increasing the availability of phenylalanine (and subsequently tyrosine), the body may have more substrate to produce melanin in depigmented areas. UVA light is thought to activate the enzyme tyrosinase, which is crucial for melanin synthesis, thereby enhancing the effect.

    Evidence Summary

    Pillser's research database contains 1 systematic review on this topic1:

    • The review examined oral phenylalanine as an adjuvant therapy with UVA exposure for vitiligo.
    • It found a beneficial, small, and statistically significant effect on repigmentation.
    • The outcome was categorized as "improved repigmentation."

    Typical Protocol

    In clinical settings, L-phenylalanine is typically taken orally (often around 50–100 mg/kg body weight) about 30–60 minutes before UVA exposure, with sessions occurring several times per week over months. Some protocols also use topical phenylalanine.

    Important Considerations

    • Not a standalone cure: The evidence suggests it works best as an adjunct to phototherapy, not as a replacement.
    • Slow process: Repigmentation can take several months of consistent treatment.
    • Medical supervision required: UVA therapy carries risks (e.g., skin aging, increased skin cancer risk) and should only be administered under a dermatologist's care.
    • PKU warning: People with phenylketonuria (PKU) cannot metabolize phenylalanine and must avoid supplementation entirely.

    Bottom Line

    L-phenylalanine used in combination with UVA therapy shows promise as an adjunctive treatment for repigmentation in vitiligo, backed by systematic review evidence indicating a small but statistically significant benefit1. However, it is not considered a first-line treatment, and you should consult a dermatologist before starting any such regimen.

    Footnotes

    1. Pillser research database, L-Phenylalanine and Improved Repigmentation. ↩ ↩2

New Topic

Browse Related Questions

Back to top